Cargando…

Pirfenidone prevents acute kidney injury in the rat

BACKGROUND: Pirfenidone is an orally active drug used for the treatment of idiopathic pulmonary fibrosis to slow loss of lung function; it acts mainly through an antifibrotic effect but also possesses antioxidant and anti-inflammatory properties. We assessed the effect of prophylactic administration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lima-Posada, Ixchel, Fontana, Francesco, Pérez-Villalva, Rosalba, Berman-Parks, Nathan, Bobadilla, Norma A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505112/ https://www.ncbi.nlm.nih.gov/pubmed/31068174 http://dx.doi.org/10.1186/s12882-019-1364-4

Ejemplares similares

Gender Differences in the Acute Kidney Injury to Chronic Kidney Disease Transition
por: Lima-Posada, Ixchel, et al.
Publicado: (2017)

SerpinA3 in the Early Recognition of Acute Kidney Injury to Chronic Kidney Disease (CKD) transition in the rat and its Potentiality in the Recognition of Patients with CKD
por: Sánchez-Navarro, Andrea, et al.
Publicado: (2019)

Hsp72 is an early and sensitive biomarker to detect acute kidney injury
por: Barrera-Chimal, Jonatan, et al.
Publicado: (2011)

Hsp72 Is a Novel Biomarker to Predict Acute Kidney Injury in Critically Ill Patients
por: Morales-Buenrostro, Luis E., et al.
Publicado: (2014)

SerpinA3K Deficiency Reduces Oxidative Stress in Acute Kidney Injury
por: González-Soria, Isaac, et al.
Publicado: (2023)

Mild ischemic Injury Leads to Long-Term Alterations in the Kidney: Amelioration by Spironolactone Administration
por: Barrera-Chimal, Jonatan, et al.
Publicado: (2015)

Sirtuin 7 Deficiency Reduces Inflammation and Tubular Damage Induced by an Episode of Acute Kidney Injury
por: Sánchez-Navarro, Andrea, et al.
Publicado: (2022)

Repeated Episodes of Ischemia/Reperfusion Induce Heme-Oxygenase-1 (HO-1) and Anti-Inflammatory Responses and Protects against Chronic Kidney Disease
por: Ortega-Trejo, Juan Antonio, et al.
Publicado: (2022)

Early triggers of moderately high‐fat diet‐induced kidney damage
por: Sánchez‐Navarro, Andrea, et al.
Publicado: (2021)

Can pirfenidone prevent tendon adhesions? An experimental study in rats
por: Türközü, Tülin, et al.
Publicado: (2023)

Effect of Fosfomycin on Cyclosporine Nephrotoxicity
por: Ortega-Trejo, Juan Antonio, et al.
Publicado: (2020)

Is Renal Ischemic Preconditioning an Alternative to Ameliorate the Short- and Long-Term Consequences of Acute Kidney Injury?
por: Ortega-Trejo, Juan Antonio, et al.
Publicado: (2023)

Pirfenidone: is it tolerable?
por: Lara, Abigail, et al.
Publicado: (2016)

Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice
por: Palacios-Ramirez, Roberto, et al.
Publicado: (2022)

Protective efficacy of pirfenidone in rats with pulmonary fibrosis induced by bleomycin
por: Demirkol, Barış, et al.
Publicado: (2023)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

Effect of Prolonged-Release Pirfenidone on Renal Function in Septic Acute Kidney Injury Patients: A Double-Blind Placebo-Controlled Clinical Trial
por: Chávez-Iñiguez, Jonathan S., et al.
Publicado: (2021)

Pirfenidone-induced Eosinophilic Pleurisy
por: Hase, Isano, et al.
Publicado: (2017)

Biphasic Effect of Pirfenidone on Angiogenesis
por: Gan, Donghao, et al.
Publicado: (2022)

Vegfa promoter gene hypermethylation at HIF1α binding site is an early contributor to CKD progression after renal ischemia
por: Sánchez-Navarro, Andrea, et al.
Publicado: (2021)

Inhibition of Ureteral Stricture by Pirfenidone-Loaded Nanoparticle-Coated Ureteral Stents with Slow-Release Pirfenidone
por: Jiang, Zhaosheng, et al.
Publicado: (2022)

Pirfenidone suppresses bleomycin-induced pulmonary fibrosis and periostin expression in rats
por: Song, Xiaoxia, et al.
Publicado: (2018)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Role of pirfenidone in the management of pulmonary fibrosis
por: Meyer, Keith C, et al.
Publicado: (2017)

Impact of Steroids on the Inflammatory Response after Ischemic Acute Kidney Injury in Rats
por: Fontana, J., et al.
Publicado: (2017)

Prevention of Acute Kidney Injury by Tauroursodeoxycholic Acid in Rat and Cell Culture Models
por: Gupta, Sandeep, et al.
Publicado: (2012)

Preventive effect of pentoxifylline on contrast-induced acute kidney injury in hypercholesterolemic rats
por: YANG, SHI-KUN, et al.
Publicado: (2015)

Prevention and Management of Acute Kidney Injury
por: Harty, John
Publicado: (2014)

Preventing Perioperative Acute Kidney Injury
por: Bhosale, Shilpushp J, et al.
Publicado: (2020)

Pirfenidone Nanoparticles Improve Corneal Wound Healing and Prevent Scarring Following Alkali Burn
por: Chowdhury, Sushovan, et al.
Publicado: (2013)

Local Delivery of Pirfenidone by PLA Implants Modifies Foreign Body Reaction and Prevents Fibrosis
por: Fayzullin, Alexey, et al.
Publicado: (2021)

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
por: Lancaster, Lisa H., et al.
Publicado: (2017)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis With Pirfenidone and Nintedanib: A Friend or Foe
por: Kaushal, Mohit, et al.
Publicado: (2022)

Effects of comorbid chronic kidney disease on mortality in idiopathic pulmonary fibrosis patients and influence of pirfenidone
por: Jo, Yong Suk, et al.
Publicado: (2023)

The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury
por: Lameire, Norbert, et al.
Publicado: (2009)

In vivo pharmacokinetic and pharmacodynamic study of co-spray-dried inhalable pirfenidone microparticles in rats
por: Kang, Ji-Hyun, et al.
Publicado: (2022)

The multifaceted role of pirfenidone and its novel targets
por: Macías-Barragán, José, et al.
Publicado: (2010)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014)

Role and New Insights of Pirfenidone in Fibrotic Diseases
por: Lopez-de la Mora, David Alejandro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ncq2h1j73ikfru0l1mbcsc9e2h